3 June 2019 in Journal of Clinical and Experimental Neuropsychology
Posterior cortical atrophy (PCA) is a rare form of dementia primarily characterized by slowly progressing deterioration of visual processing corresponding to atrophy in the posterior parietal and occipital cortices with less prominent memory loss than are usually seen in other forms of dementia such as Alzheimer’s Disease (AD). In the present case report, we describe longitudinal data over a period of 11 years regarding clinical and neuropsychological impairments and their relation to the location and extent of cortical changes related to higher order visual processing in a patient with posterior cortical atrophy. In our patient, visual processing deficits concerning space, motion and object perception emerged at the age of 50 and continued to worsen. By the age of 58, while the perception of contrast, color and figure-ground separation appeared undisturbed the patient exhibited pronounced dorsal- and ventral-related visual deficits, which continued to worsen with age. The patient’s MRI scans over the course of the disease revealed increasing circumscribed and bilateral atrophy of the parietal and occipital cortices, with a right-sided predominance. The specific localization of cortical atrophy, the slow progression characterized by visual processing deficits and relatively preserved memory were the main criteria for the diagnosis of posterior cortical atrophy. The case report also highlights the importance of an early extensive neurological and neuropsychological evaluation of visual deficits that occur without the presence of ophthalmological disease.
1 January 2021 in Archives of Biological Sciences
We investigated two structures that are in close association with the pyramidal lobe of the thyroid gland. Our investigation was performed using microdissection and histological examination in 106 human postmortem specimens. The first investigated structure was identified as the thyroid fibrous band that was present in 28.3% of cases. This band was always associated with the pyramidal lobe (which was significantly longer and thicker when associated with this band) and it had a constant hyo-pyramidal extension; it was located close to the midsagittal plane and predominantly composed of dense irregular connective tissue. The second investigated structure was the levator glandulae thyroideae muscle, which was associated with the pyramidal lobe in only 13.6% of cases. This muscle had a double extension, hyo-pyramidal and laryngo-pyramidal, located farther from the midsagittal plane, it was longer and thinner than the thyroid fibrous band and predominantly composed of striated muscle fibers. We confirmed our hypothesis that the thyroid fibrous band, which may be considered as the partial fibrous remnant of the thyroglossal duct and levator glandulae thyroideae, and which may be considered as infrahyoid or laryngeal muscle, are two different structures of the thyroid gland.
1 January 2026 in Medicinska istrazivanja
The integration of artificial intelligence with advanced neuroimaging techniques represents one of the most important developments in contemporary neuroscience and clinical neuroanatomy. This narrative review summarizes how machine learning and deep learning methods can be applied to neuroimaging data to reveal hidden anatomical and functional brain patterns with direct clinical relevance. Neuroanatomy plays a central role in this process, providing the structural framework for interpreting functional, metabolic, and electrophysiological signals. Artificial intelligence-based analysis enables the detection of subtle alterations in gray and white matter, the analysis of brain networks and pathways, and the integration of multimodal imaging data beyond the limits of human perception and conventional statistical approaches. In addition to aiding physicians in establishing the correct diagnosis, these capabilities contribute to earlier and more accurate diagnoses, improved disease differentiation, identification of affected structures within specific health conditions or diseases, and more reliable prognostic assessment. In addition to diagnostic applications, artificial intelligence supports the development of personalized therapeutic strategies, including targeted neuromodulation, neuroimaging-guided surgery, adaptive brain-computer interfaces, and an individualized approach in further disease monitoring. Despite existing challenges related to data heterogeneity, model interpretability, and ethical regulation, the synergy between AI and neuroimaging represents a critical step toward personalized medicine. By leveraging detailed neuroanatomical information, artificial intelligence-driven approaches enable therapies tailored to the unique brain structure and network organization of each individual.